Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lazard Global Total Return and Income Fund | LGI | Apr 19, 2024 | 14.90 | -0.33 |
Lazydays | GORV | Apr 19, 2024 | 3.57 | 0.00 |
LCI Industries | LCII | Apr 19, 2024 | 106.42 | +2.14 |
LCNB | LCNB | Apr 19, 2024 | 14.97 | +1.35 |
Lead Real Estate ADR | LRE | Apr 19, 2024 | 3.26 | -0.03 |
Leafly | LFLY | Apr 19, 2024 | 2.17 | -2.25 |
Leap Therapeutics | LPTX | Apr 19, 2024 | 2.80 | -5.41 |
Lear | LEA | Apr 19, 2024 | 132.86 | +1.30 |
Learn CW Investment SPAC | LCW | Apr 19, 2024 | 10.93 | -0.09 |
LeddarTech | LDTC | Apr 19, 2024 | 2.15 | 0.00 |
Lee Enterprises | LEE | Apr 19, 2024 | 12.87 | +0.47 |
Legacy Housing | LEGH | Apr 19, 2024 | 19.99 | +2.04 |
LegalZoom.com | LZ | Apr 19, 2024 | 11.73 | -0.68 |
Legato Merger III | LEGT | Apr 19, 2024 | 10.12 | 0.00 |
Legend Biotech ADR | LEGN | Apr 19, 2024 | 46.19 | -1.97 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Apr 19, 2024 | 35.75 | +1.44 |
Leggett & Platt | LEG | Apr 19, 2024 | 18.26 | +3.28 |
Leidos | LDOS | Apr 19, 2024 | 124.91 | +0.93 |
Leju ADR | LEJU | Apr 19, 2024 | 1.10 | 0.00 |
LeMaitre Vascular | LMAT | Apr 19, 2024 | 63.26 | +1.02 |
Lemonade | LMND | Apr 19, 2024 | 15.86 | +0.83 |
LendingClub | LC | Apr 19, 2024 | 7.90 | +3.81 |
LendingTree | TREE | Apr 19, 2024 | 34.13 | -0.44 |
Lendway | LDWY | Apr 19, 2024 | 6.11 | 0.00 |
Lennar A | LEN | Apr 19, 2024 | 150.19 | -1.51 |
Lennar B | LEN-B | Apr 19, 2024 | 137.06 | -1.54 |
Lennox International | LII | Apr 19, 2024 | 457.15 | -0.32 |
LENSAR | LNSR | Apr 19, 2024 | 3.23 | +2.87 |
LENZ Therapeutics | LENZ | Apr 19, 2024 | 16.02 | 0.00 |
Leonardo DRS | DRS | Apr 19, 2024 | 20.95 | -1.41 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.